More importantly, BCL-XL/MCL-1 co-dependent tumor cells cannot be safely targeted with the currently available inhibitors because the combination of BCL-XL and MCL-1 inhibitors causes severe tissue damage and lethality in mice [22–24]. This evidence concerns the gene MCL1 and neoplasm.